Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.

Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects. The literature su...

Full description

Bibliographic Details
Main Authors: Susan J M Hoonhorst, Nick H T ten Hacken, Judith M Vonk, Wim Timens, Pieter S Hiemstra, Thérèse S Lapperre, Peter J Sterk, Dirkje S Postma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3914834?pdf=render
id doaj-e79dad5c505241379db575fde9d75fd6
record_format Article
spelling doaj-e79dad5c505241379db575fde9d75fd62020-11-25T00:08:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8744310.1371/journal.pone.0087443Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.Susan J M HoonhorstNick H T ten HackenJudith M VonkWim TimensPieter S HiemstraThérèse S LapperrePeter J SterkDirkje S PostmaInhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects. The literature suggests that cigarette smoking causes ICS insensitivity. The aim of this study is to compare anti-inflammatory effects of ICS in persistent smokers and persistent ex-smokers in a post-hoc analysis of the GLUCOLD study.Persistent smokers (n = 41) and persistent ex-smokers (n = 31) from the GLUCOLD cohort were investigated. Effects of ICS treatment compared with placebo were estimated by analysing changes in lung function, hyperresponsiveness, and inflammatory cells in sputum and bronchial biopsies during short-term (0-6 months) and long-term (6-30 months) treatment using multiple regression analyses.Bronchial mast cells were reduced by short-term and long-term ICS treatment in both smokers and ex-smokers. In contrast, CD3⁺, CD4⁺, and CD8⁺ cells were reduced by short-term ICS treatment in smokers only. In addition, sputum neutrophils and lymphocytes, and bronchial CD8⁺ cells were reduced after long-term treatment in ex-smokers only. No significant interactions existed between smoking and ICS treatment.Even in the presence of smoking, long-term ICS treatment may lead to anti-inflammatory effects in the lung. Some anti-inflammatory ICS effects are comparable in smokers and ex-smokers with COPD, other effects are cell-specific. The clinical relevance of these findings, however, are uncertain.http://europepmc.org/articles/PMC3914834?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Susan J M Hoonhorst
Nick H T ten Hacken
Judith M Vonk
Wim Timens
Pieter S Hiemstra
Thérèse S Lapperre
Peter J Sterk
Dirkje S Postma
spellingShingle Susan J M Hoonhorst
Nick H T ten Hacken
Judith M Vonk
Wim Timens
Pieter S Hiemstra
Thérèse S Lapperre
Peter J Sterk
Dirkje S Postma
Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
PLoS ONE
author_facet Susan J M Hoonhorst
Nick H T ten Hacken
Judith M Vonk
Wim Timens
Pieter S Hiemstra
Thérèse S Lapperre
Peter J Sterk
Dirkje S Postma
author_sort Susan J M Hoonhorst
title Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
title_short Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
title_full Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
title_fullStr Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
title_full_unstemmed Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.
title_sort steroid resistance in copd? overlap and differential anti-inflammatory effects in smokers and ex-smokers.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects. The literature suggests that cigarette smoking causes ICS insensitivity. The aim of this study is to compare anti-inflammatory effects of ICS in persistent smokers and persistent ex-smokers in a post-hoc analysis of the GLUCOLD study.Persistent smokers (n = 41) and persistent ex-smokers (n = 31) from the GLUCOLD cohort were investigated. Effects of ICS treatment compared with placebo were estimated by analysing changes in lung function, hyperresponsiveness, and inflammatory cells in sputum and bronchial biopsies during short-term (0-6 months) and long-term (6-30 months) treatment using multiple regression analyses.Bronchial mast cells were reduced by short-term and long-term ICS treatment in both smokers and ex-smokers. In contrast, CD3⁺, CD4⁺, and CD8⁺ cells were reduced by short-term ICS treatment in smokers only. In addition, sputum neutrophils and lymphocytes, and bronchial CD8⁺ cells were reduced after long-term treatment in ex-smokers only. No significant interactions existed between smoking and ICS treatment.Even in the presence of smoking, long-term ICS treatment may lead to anti-inflammatory effects in the lung. Some anti-inflammatory ICS effects are comparable in smokers and ex-smokers with COPD, other effects are cell-specific. The clinical relevance of these findings, however, are uncertain.
url http://europepmc.org/articles/PMC3914834?pdf=render
work_keys_str_mv AT susanjmhoonhorst steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT nickhttenhacken steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT judithmvonk steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT wimtimens steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT pietershiemstra steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT thereseslapperre steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT peterjsterk steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
AT dirkjespostma steroidresistanceincopdoverlapanddifferentialantiinflammatoryeffectsinsmokersandexsmokers
_version_ 1725415332920688640